Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
US Stock MarketDetailed Quotes
SKYE BIOSCIENCE INC (SKYE)
- 0.4812
- +0.0095+2.01%
Trading Aug 7 13:54 ET
16.91MMarket Cap-0.33P/E (TTM)
0.5400High0.4650Low295.34KVolume0.4900Open0.4717Prev Close147.19KTurnover1.29%Turnover RatioLossP/E (Static)35.14MShares4.990252wk High1.88P/B11.05MFloat Cap0.276052wk Low--Dividend TTM22.97MShs Float64.7250Historical High--Div Yield TTM15.90%Range %0.2760Historical Low0.4984Avg Price1Lot Size
SKYE BIOSCIENCE INC (SKYE) News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Skye Bioscience Moves Listing to Nasdaq Capital Market
Express News | Brand Engagement Network, Grupo Skye, and Knobloch Information Group Advance Skye Salud to Phase 2 Clinical Evaluation in Mexico
Brand Engagement Network Forms INTERVENT Health AI JV With INTERVENT International To Develop, Deploy And Commercialize AI-Powered Health Coaching Solutions
Express News | Brand Engagement Network - Intervent Health AI and Skye AI USA Enter Five-Year Exclusive North American Arrangement - SEC Filing
Skye Bioscience Expands Authorized Shares After Shareholder Approval
Analyst Reiterates Buy on Skye Bioscience, Maintains $20 Price Target on Positive Nimacimab Safety and Efficacy Data
Skye Bioscience Says Cohort Review Committee Unanimously Approves Opening Second Cohort Of CBeyond Part C Expansion Study
Express News | Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data From First Four Participants Treated in Cohort 1
Skye Bioscience Faces Nasdaq Compliance Risk Over Equity
Piper Sandler Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating, Cuts Target Price to $6
William Blair Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Coherus Biosciences (CHRS), Moderna (MRNA) and Skye Bioscience (SKYE)
Express News | Skye Bioscience Inc : Piper Sandler Cuts Target Price to $6 From $13
Skye Bioscience Q1 EPS $(0.32) Misses $(0.31) Estimate
SKYE BIOSCIENCE INC | 10-Q: Q1 2026 Earnings Report
Express News | Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
Skye Bioscience Treats First Patient In Part C Expansion Study Of CBeyond Phase 2a Trial To Characterize Safety And PK At Exposures To Challenge Peripheral Restriction Of Nimacimab Through IV Administration Over 16 Weeks Of Treatment
Express News | Skye Bioscience Inc - Topline Data From Expansion Study Expected in Q4 2026
Express News | Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2B Dose Selection for GLP-1 Combination Development
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm